Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Carvedilol, a pharmacological antioxidant, inhibits neointimal matrix metalloproteinase-2 and -9 in experimental atherosclerosis.

Carvedilol, a pharmacological antioxidant, inhibits neointimal matrix metalloproteinase-2 and -9 in experimental atherosclerosis. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Carvedilol, a pharmacological antioxidant, inhibits neointimal matrix metalloproteinase-2 and -9 in experimental atherosclerosis. Abstract Text:

    tao-cheng wuTao-Cheng Wu,yung-hsiang chenYung-Hsiang Chen,hsin-bang leuHsin-Bang Leu,yuh-lien chenYuh-Lien Chen,feng-yen linFeng-Yen Lin,shing-jong linShing-Jong Lin,jaw-wen chenJaw-Wen Chen,tao-cheng wuTao-Cheng Wu,yung-hsiang chenYung-Hsiang Chen,hsin-bang leuHsin-Bang Leu,yuh-lien chenYuh-Lien Chen,feng-yen linFeng-Yen Lin,shing-jong linShing-Jong Lin,jaw-wen chenJaw-Wen Chen,tao-cheng wuTao-Cheng Wu,yung-hsiang chenYung-Hsiang Chen,hsin-bang leuHsin-Bang Leu,yuh-lien chenYuh-Lien Chen,feng-yen linFeng-Yen Lin,shing-jong linShing-Jong Lin,jaw-wen chenJaw-Wen Chen,

    Matrix metalloproteinase (MMP) is critical to the progression of atherosclerosis and neointima hyperplasia after vascular injury. We investigated the effects of carvedilol, a pharmacological antioxidant with alpha- and beta-adrenergic blocking activity, on MMP-2 and MMP-9 expression. Vascular injury was induced with the balloon catheters on abdominal aortas of high-cholesterol-fed rabbits. On Day 21, there was significant aortic neointima formation with increased oxidative DNA damage by immunostaining with 8-hydroxy-2'-deoxyguanosine and enhanced MMP-2 and MMP-9 expressions by Western blotting, which were significantly reduced by oral administration of carvedilol (20 mg/kg/day) or probucol (100 mg/kg/day). Vascular expression (by Western blot), activity (by gelatin zymography), and mRNA levels of MMP-2 and MMP-9 were also reduced by carvedilol or probucol. Besides, pretreatment with carvedilol or probucol but not propranolol, a beta-blocker, or prazocin, an alpha-blocker, inhibited tumor necrosis factor-alpha-stimulated expressions and activities of MMP-2 and MMP-9 in human aortic smooth muscle cells. On electrophoretic mobility-shift assay, carvedilol inhibited the binding activities of activator protein-1 and specific protein-1, two major transcription factors for MMP promoter regions. Accordingly, carvedilol, a pharmacological antioxidant, inhibited in vivo and in vitro expression of MMP-2 and MMP-9 properly by modulating the redox-related pathways, suggesting its potential clinical implications.

    Carvedilol, a pharmacological antioxidant, inhibits neointimal matrix metalloproteinase-2 and -9 in experimental atherosclerosis. Publishing Authors By Initials

    tc wuTC Wu,yh chenYH Chen,hb leuHB Leu,yl chenYL Chen,fy linFY Lin,sj linSJ Lin,jw chenJW Chen,tc wuTC Wu,yh chenYH Chen,hb leuHB Leu,yl chenYL Chen,fy linFY Lin,sj linSJ Lin,jw chenJW Chen,tc wuTC Wu,yh chenYH Chen,hb leuHB Leu,yl chenYL Chen,fy linFY Lin,sj linSJ Lin,jw chenJW Chen,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Carvedilol, a pharmacological antioxidant, inhibits neointimal matrix metalloproteinase-2 and -9 in experimental atherosclerosis. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Free radical biology & medicine

    VOLUME: 43

    Page Numbers: 1508-22

    Journal Abbreviation: Free Radic. Biol. Med.

    ISSN: 0891-5849

    DAY: 24

    MONTH: 08

    YEAR: 2007

    Carvedilol, a pharmacological antioxidant, inhibits neointimal matrix metalloproteinase-2 and -9 in experimental atherosclerosis. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8709159

    Carvedilol, a pharmacological antioxidant, inhibits neointimal matrix metalloproteinase-2 and -9 in experimental atherosclerosis. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Carvedilol, a pharmacological antioxidant, inhibits neointimal matrix metalloproteinase-2 and -9 in experimental atherosclerosis. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Carvedilol, a pharmacological antioxidant, inhibits neointimal matrix metalloproteinase-2 and -9 in experimental atherosclerosis.

    AFFILIATION: Institute of Clinical Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan, Republic of China; Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, Republic of China.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Free Radic Biol Med

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Carvedilol, a pharmacological antioxidant, inhibits neointimal matrix metalloproteinase-2 and -9 in experimental atherosclerosis Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News